GIP and Glucose intolerance: Collectively, these data illustrate that reducing the production of proglucagon products from α cells leads to impaired α cell–to–β cell communication, reductions in insulin secretion, and glucose intolerance across a variety of physiological interventions, which is masked to a degree by the enhanced sensitivity to GIP.